PharmaIN Corp. (specializing in peptide formulation and delivery) highly appreciated the opportunity to asses PGC-GLP-1 for reversal of T1D and very much grateful to NIDDK for the study. The gene discussed is GCG; the disease is type 1 diabetes mellitus.